Analysts forecast that Accuray Incorporated (NASDAQ:ARAY) will report ($0.01) earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Two analysts have made estimates for Accuray’s earnings. Accuray also posted earnings per share of ($0.01) in the same quarter last year. The firm is expected to report its next quarterly earnings report after the market closes on Wednesday, August 11th.
According to Zacks, analysts expect that Accuray will report full-year earnings of $0.03 per share for the current year, with EPS estimates ranging from $0.01 to $0.04. For the next fiscal year, analysts anticipate that the business will report earnings of $0.08 per share, with EPS estimates ranging from $0.02 to $0.11. Zacks’ earnings per share averages are an average based on a survey of research firms that follow Accuray.
Separately, Zacks Investment Research downgraded Accuray from a “hold” rating to a “sell” rating and set a $5.00 price target for the company. in a research note on Thursday, April 29th.
ARAY stock traded down $0.04 during mid-day trading on Friday, reaching $4.14. The company had a trading volume of 400 shares, compared to its average volume of 477,960. The company has a debt-to-equity ratio of 2.09, a current ratio of 1.86 and a quick ratio of 1.15. The stock’s 50 day moving average is $4.40. The company has a market capitalization of $386.10 million, a P/E ratio of 103.53 and a beta of 1.87. Accuray has a 52 week low of $2.17 and a 52 week high of $6.01.
Accuray Incorporated designs, develops, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body in the Americas, Europe, the Middle East, India, Japan, Africa, and rest of the Asia Pacific region. The company offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body.
Featured Article: What is Forex?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Accuray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Accuray and related companies with MarketBeat.com's FREE daily email newsletter.